ESTRO 2022 - Abstract Book

S477

Abstract book

ESTRO 2022

Conclusion Even small variations in OAR delineation led to high over-dosage of OAR. Extensive QA with consecutive delineation and dose planning rounds decreased variability in OAR delineation and dose planning and emphasises the need of thorough QA while conducting a multicentre trial.

Mini-Oral: 14: Urology

MO-0551 Short-term RT for early PCa with concomitant boost to the DIL (phase II trial AIRC-IG-13218)-updates

G. Corrao 1 , G. Marvaso 1 , M. Pepa 2 , M. Zaffaroni 2 , M.G. Vincini 2 , F. Bellerba 3 , S. Gandini 3 , S. Volpe 1 , D.P. Rojas 2 , D. Zerini 2 , C.I. Fodor 2 , P. Pricolo 4 , S. Alessi 4 , G. Petralia 5 , F.A. Mistretta 6 , R. Cambria 7 , F. Cattani 2 , O. De Cobelli 8 , R. Orecchia 9 , B.A. Jereczek-Fossa 10